Lopez-Rodriguez, A.B.; Decouty-Perez, C.; Farré-Alins, V.; Palomino-AntolÃn, A.; Narros-Fernández, P.; Egea, J.
Activation of NLRP3 Is Required for a Functional and Beneficial Microglia Response after Brain Trauma. Pharmaceutics 2022, 14, 1550.
https://doi.org/10.3390/pharmaceutics14081550
AMA Style
Lopez-Rodriguez AB, Decouty-Perez C, Farré-Alins V, Palomino-AntolÃn A, Narros-Fernández P, Egea J.
Activation of NLRP3 Is Required for a Functional and Beneficial Microglia Response after Brain Trauma. Pharmaceutics. 2022; 14(8):1550.
https://doi.org/10.3390/pharmaceutics14081550
Chicago/Turabian Style
Lopez-Rodriguez, Ana Belen, Céline Decouty-Perez, Victor Farré-Alins, Alejandra Palomino-AntolÃn, Paloma Narros-Fernández, and Javier Egea.
2022. "Activation of NLRP3 Is Required for a Functional and Beneficial Microglia Response after Brain Trauma" Pharmaceutics 14, no. 8: 1550.
https://doi.org/10.3390/pharmaceutics14081550
APA Style
Lopez-Rodriguez, A. B., Decouty-Perez, C., Farré-Alins, V., Palomino-AntolÃn, A., Narros-Fernández, P., & Egea, J.
(2022). Activation of NLRP3 Is Required for a Functional and Beneficial Microglia Response after Brain Trauma. Pharmaceutics, 14(8), 1550.
https://doi.org/10.3390/pharmaceutics14081550
